Pricing Log in Create free account

Polaryx Therapeutics, Inc. (PLYX) vs PMV Pharmaceuticals, Inc. (PMVP)

Polaryx Therapeutics, Inc. and PMV Pharmaceuticals, Inc. are both Biotechnology companies. Polaryx Therapeutics, Inc. and PMV Pharmaceuticals, Inc. are of similar size ($96.7M and $94.4M). Across the 8 metrics below, Polaryx Therapeutics, Inc. leads on 6 and PMV Pharmaceuticals, Inc. on 2.

Valuation

Metric PLYX PMVP Biotechnology median
P/E n/m n/m 10.96
P/S n/m n/m 9.52
P/B 8.39 0.92 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m 0.17 0.68
EV/Sales n/m n/m 9.00
Earnings yield (11.39%) (115.45%) (32.09%)
Free cash flow yield (8.98%) (108.52%) (22.62%)

Profitability

Metric PLYX PMVP Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (70.93%) (50.12%)
Return on assets (169.05%) (64.04%) (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PLYX PMVP Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) 77.72% (29.82%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric PLYX PMVP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.53 7.70 4.74
Net debt to EBITDA 0.66 1.27 1.01

Dividend

Metric PLYX PMVP Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric PLYX PMVP Biotechnology median
Market cap 96.70m 94.39m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack